Early invasive strategy improves outcomes in patients with acute coronary syndrome with previous coronary artery bypass graft surgery: A report from TACTICS-TIMI 18

Critical Pathways in Cardiology

Volumn 5, Issue 3, 2006, Pages 167-172

  Kugelmass, Aaron D ^a   Sadanandan, Saihari ^b   Lakkis, Nasser ^c   Dibattiste, Peter M ^d   Robertson, Debbie H ^d   Demopoulos, Laura A ^e   Gibson, C Michael ^f   Weintraub, William S ^g   Murphy, Sabina A ^f   Cannon, Christopher P ^f  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

Angina; Angiography; Grafting; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; INCIDENCE; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33748608580     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000236218.07432.a6     Document Type: Article

References (20)

1. Passamani E, Davis K, Gillespie M, et al. CASS principal investigators: a randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665-1671.
2. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311:1333-1339.
3. American Heart Association Statistics. Available at: www.americanheart. org. 2006.
4. Campeau L, Lesperance J, Bourassa M. Natural history of saphenous vein aortocoronary bypass grafts. Mod Concepts Cardiovasc Dis. 1984;53:59-63.
5. Fitzgibbon G, Kafka H, Leach A, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626.
6. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15 year period. N Engl J Med. 1996;334:216-219.
7. Kleiman N, Anderson H, Rogers W, et al. Comparison of patients with unstable angina and non-q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry). Am J Cardiol. 1996;77:227-231.
8. Waters DD, Walling A, Roy D, et al. Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris. Am J Cardiol. 1986;58:465-469.
9. Wiseman A, Waters DD, Walling A, et al. Long-term prognosis after myocardial infarction in patients with previous coronary artery bypass surgery. J Am Coll Cardiol. 1988;12:873-880.
10. Labinaz M, Kilaru R, Pieper K, et al. Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using Integrelin therapy (PURSUIT) trial. Circulation. 2002;105:322-327.
11. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002. Summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation. 2002;106:1893-1900.
12. Cannon CP, Weintraub WS, Demopoulous LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-1887.
13. Fragmin and fast revascularization during instability in coronary artery disease (FRISC II) investigators. Invasive compared to non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized trial. Lancet. 1999;354:708-715.
14. Fox KAA, Poole-Wilson PA, Henderson RA, et al. 5 year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet. 2005;366:914-920.
15. Cannon CP, Weintraub WS, Demopoulous LA, et al. Invasive versus conservative strategies in unstable angina and non-q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Am J Cardiol. 1998;82:731-736.
16. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659-665.
17. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol. 1994;23:1296-1304.
18. Loop FD, Lytle BW, Cosgrove DM, et al. Reoperation for coronary atherosclerosis: changing practice in 2509 consecutive patients. Ann Surg. 1990;212:378-385.
19. Weintraub WS, Jones EL, Craver JM, et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation. 1995;92:II50-II57.
20. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868-877.